Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$29 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0641
D

Failure to Accurately Code Depression and Care Plan for Psychotropic Use on MDS

Los Angeles, California Survey Completed on 01-27-2026

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

Surveyors identified that the facility failed to ensure an accurate MDS assessment and related care planning for a resident with a documented diagnosis of depression. The resident was admitted with Parkinson’s disease, muscle weakness, and difficulty walking, and had an active order for Mirtazapine 15 mg for depression manifested by overconcern with health issues. The resident’s MDS indicated they felt little interest or pleasure in doing things and felt down, depressed, or hopeless half or more of the days, but depression was not coded as an active diagnosis on the MDS. During interview and record review, an LVN confirmed there was no care plan addressing depression and that the diagnosis of depression was not triggered on the MDS, despite the resident receiving a medication ordered for depression. Further review with the DON and MDS nurse showed that the resident had received a depression diagnosis from the hospital and that a psychiatrist at the GACH had continued the Mirtazapine upon readmission. The MDS nurse stated that once the order was entered into the electronic chart, there was no alert to trigger the depression diagnosis in the MDS. Review of the IDT care conference documentation showed no recorded review of medications, and the DON and MDS nurse confirmed there was no care plan documented for depression or for the use of Mirtazapine. The DON and MDS nurse stated that without a care plan, something could be missed, and that the care plan is the comprehensive plan of care for the resident. The facility’s psychotropic medication use policy required that residents not receive psychotropic medications without a clinically indicated, documented condition and that the IDT evaluate and document the resident’s underlying condition and medications on admission or readmission, which was not reflected in the records reviewed for this resident.

Long-term care team reviewing survey readiness and plan of correction

We Help Long-Term Care Teams Stay Survey-Ready

We process and analyze inspection reports and plan of correction using AI to extract insights and trends so providers can improve care quality and stay ahead of compliance risks.

Discover our solutions:

An unhandled error has occurred. Reload 🗙